Generalized Myasthenia Gravis Clinical Trials in Chicago, Illinois

4 studies are recruiting for generalized myasthenia gravis in Chicago, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

   The purpose of this study is to assess the pharmacokinetics, pharmacodynamics, safety, tolerability, immunogenicity and activity of zilucoplan (ZLP) in pediatric study participants with generalized myasthenia gravis (gMG).

   Stage

   Phase 2

   Ages

   12 to 17

   Site

   Mg0014 50168, Chicago, Illinois

   Locations

   9 in total

   Run by

   UCB Biopharma SRL

   See if you can join NCT06055959 on ClinicalTrials.gov

2. A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

   A study to evaluate the efficacy, safety and tolerability of Remibrutinib versus placebo in adult patients with Generalized Myasthenia Gravis who are on stable, standard-of-care (SOC) treatment.

   Stage

   Phase 3

   Ages

   18 to 85

   Site

   University of Chicago Medical Centr, Chicago, Illinois

   Locations

   130 in total

   Run by

   Novartis Pharmaceuticals

   See if you can join NCT06744920 on ClinicalTrials.gov

3. A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab

   This is a prospective, multicenter single arm study designed to evaluate the effectiveness and safety of a predefined oral corticosteroids (OCS) tapering schedule to reduce OCS use in adult participants with acetylcholine receptor positive (AChR+) generalized myasthenia gravis (gMG) being treated w…

   Stage

   Phase 4

   Ages

   18 and older

   Site

   Research Site, Chicago, Illinois

   Locations

   12 in total

   Run by

   Alexion Pharmaceuticals, Inc.

   See if you can join NCT07221838 on ClinicalTrials.gov

4. Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis

   The purpose of this trial is to investigate the PK, PD, safety, and activity of efgartigimod IV in children and adolescents aged from 2 to less than 18 years of age with gMG. Trial details include: * The maximum trial duration for each individual participant will be approximately 28 weeks * The tre…

   Stage

   Phase 2

   Ages

   2 to 18

   Site

   Ann and Robert H Lurie Children's Hospital of Chicago - Main Hospital, Chicago, Illinois

   Locations

   25 in total

   Run by

   argenx

   See if you can join NCT04833894 on ClinicalTrials.gov